15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
8
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.

Vanderbilt University School of Medicine
22
Bile acid conjugates of a nonsteroidal glucocorticoid receptor modulator.

Abbott Laboratories
14
Novel mechanistic insights - A brand new Era for anti-HBV drugs.

Peking University
51
Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT.

Justus Liebig University of Giessen
30
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure.

Bristol Myers Squibb
8
Recent advances in steroid amino acid conjugates: Old scaffolds with new dimensions.

Panjab University
56
Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic Pain.

Bristol Myers Squibb
24
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.

Southwest Jiaotong University
10
Synthesis and biological evaluation of novel steroidal pyrazoles as substrates for bile acid transporters.

Xenoport
29
Discovery of (

Bristol Myers Squibb
10
Design of Dimeric Bile Acid Derivatives as Potent and Selective Human NTCP Inhibitors.

National Institute of Biological Sciences
2
Potent and Specific Inhibition of NTCP-Mediated HBV/HDV Infection and Substrate Transporting by a Novel, Oral-Available Cyclosporine A Analogue.

National Institute of Biological Sciences
9
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.

Southwest Jiaotong University
59
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

Oryzon Genomics
19
Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists

Boehringer Ingelheim International